Dr. Marquart is a Clinical Genomics Director at PierianDx. He obtained his Ph.D. in Biochemistry and Molecular Biology from Saint Louis University. While at SLU, he published several high impact papers and forged lab partnerships with pharmaceutical companies. After obtaining his Ph.D., Tyler worked with Abbott Molecular developing now FDA-approved oncology-based real time PCR assays and performed field training at clinical research organizations. With PierianDx, Marquart has played an instrumental role in bringing commercial laboratories up to speed, helping to diagnose hitches in the pipeline that acts as barriers to bringing their assays to market.